Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin 5 receptor alpha subunit (IL-5Rα) is a receptor for interleukin-5 (IL-5), a cytokine critical for the development, activation, survival, and function of eosinophils. It forms a heterodimeric receptor complex with the common beta chain (βc), which is shared with the receptors for interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF). IL-5Rα is primarily expressed on eosinophils, basophils, and some B cells. Binding of IL-5 to IL-5Rα triggers intracellular signaling cascades, primarily via the JAK/STAT pathway, leading to the biological effects of IL-5. As a key regulator of eosinophil biology, IL-5Rα is a therapeutic target for eosinophil-mediated diseases, such as asthma and hypereosinophilic syndromes. Monoclonal antibodies and peptide antagonists targeting IL-5Rα are being developed to block IL-5 signaling and reduce eosinophil activity.
Antibody-mediated antagonism of IL-5Rα signaling; sequestration of IL-5Rα chains to prevent receptor assembly/dimerization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 5 Receptor Alpha Subunit (IL-5Rα).